SeaStar Medical Holding (ICU) has released an update.
SeaStar Medical Holding Corporation has announced that the FDA has approved their Selective Cytopheretic Device Pediatric for children over 10 kilograms suffering from acute kidney injury and sepsis, for use in hospital ICUs. This marks a significant step forward for the company and offers a new treatment option for pediatric care in critical conditions.
For further insights into ICU stock, check out TipRanks’ Stock Analysis page.
